IRIS
VIGORITA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.417
EU - Europa 1.477
AS - Asia 1.164
SA - Sud America 450
AF - Africa 31
OC - Oceania 2
Totale 5.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.382
SG - Singapore 494
BR - Brasile 401
IE - Irlanda 400
SE - Svezia 389
CN - Cina 368
UA - Ucraina 198
DE - Germania 156
HK - Hong Kong 137
FI - Finlandia 77
GB - Regno Unito 64
IT - Italia 61
RU - Federazione Russa 59
IN - India 35
VN - Vietnam 33
AR - Argentina 19
FR - Francia 19
CA - Canada 17
PL - Polonia 13
IR - Iran 12
MX - Messico 12
UZ - Uzbekistan 12
BD - Bangladesh 11
TR - Turchia 9
BE - Belgio 8
ZA - Sudafrica 8
ID - Indonesia 7
IQ - Iraq 7
MA - Marocco 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
VE - Venezuela 6
ES - Italia 5
GR - Grecia 5
JO - Giordania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
KE - Kenya 4
CL - Cile 3
JP - Giappone 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
NL - Olanda 2
PH - Filippine 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
HR - Croazia 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 5.541
Salva come PNG Salva come JPEG
Città #
Dublin 399
Jacksonville 352
Dallas 331
Chandler 275
Nyköping 265
Singapore 229
Ashburn 225
Dearborn 188
Beijing 160
Hong Kong 137
Cambridge 61
Medford 61
Princeton 61
Los Angeles 52
Ann Arbor 45
The Dalles 42
Boardman 40
Des Moines 37
Buffalo 33
São Paulo 31
Munich 28
Jinan 26
New York 26
Ho Chi Minh City 21
Lancaster 21
San Mateo 21
Tianjin 19
Haikou 12
Phoenix 12
Turku 12
Warsaw 12
Woodbridge 12
Belo Horizonte 11
Rio de Janeiro 11
Tashkent 11
Ardabil 10
Brasília 10
Montreal 10
Shenyang 10
Wilmington 10
Moscow 9
Nanchang 9
Santa Clara 9
Brussels 8
Guangzhou 8
Nanjing 8
Seattle 7
Bremen 6
Changsha 6
Chennai 6
Contagem 6
Guarulhos 6
Hebei 6
Houston 6
Redondo Beach 6
Stockholm 6
Turin 6
Amman 5
Baghdad 5
Boston 5
Brno 5
Curitiba 5
Dhaka 5
Fuzhou 5
Goiânia 5
Hangzhou 5
Milan 5
Monmouth Junction 5
Ningbo 5
Pune 5
San Francisco 5
Sorocaba 5
Taiyuan 5
Taizhou 5
Washington 5
Zhengzhou 5
Asunción 4
Atlanta 4
Augusta 4
Frankfurt am Main 4
Hanoi 4
Helsinki 4
Istanbul 4
Johannesburg 4
London 4
Mumbai 4
Norwalk 4
Praia Grande 4
Santo André 4
Volta Redonda 4
Anápolis 3
Brooklyn 3
Camaçari 3
Campinas 3
Düsseldorf 3
Florianópolis 3
Hefei 3
Hortolândia 3
Hyderabad 3
Louisville 3
Totale 3.628
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 168
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 145
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 130
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 129
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 128
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 124
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 123
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 123
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 119
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 118
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 116
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 113
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 113
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 110
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 109
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 108
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 106
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 105
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 104
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 104
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 101
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 101
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 96
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 95
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 93
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 92
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 91
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 90
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 87
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 87
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 86
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 85
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 81
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 81
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 80
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 80
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 80
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 79
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 79
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 79
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 78
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 77
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 77
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 75
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 74
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 74
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 73
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 73
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 72
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 71
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 71
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 70
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 68
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 65
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 64
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 64
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 61
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 58
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 56
Reattività di isonicotinoilidrazoni con diazometano 52
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 50
Totale 5.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 50 5 49 1 53 67 11
2021/2022413 6 94 3 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/20251.093 13 9 19 79 42 33 42 212 297 65 107 175
2025/20261.310 180 318 296 241 241 34 0 0 0 0 0 0
Totale 5.561